ARCORAL PHARMA AS
Organization
- CEO
- VJ
Vibeke Johansen1977
- Chairman of the board
- BT
- Years since formation
- 14 years
- since Mar 9, 2011
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 5
- 1 company, 4 persons
Financials
- Annual total result 2024
- -70,196
- NOK
- Total equity 2024
- 281,749
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
VJ 1977 | Managing Director/CEO | 28 % directly |
Board
| Name | Role | Shares |
|---|---|---|
BT | Chairman | 6 % directly |
| Board Member | 28 % directly | |
VJ 1977 | Board Member | 28 % directly |
RH | Board Member | 10 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
VJ 1977 | Managing Director/CEO, Board Member | 28 % directly |
| Board Member | 28 % directly | |
LJ 1970 | - | 28 % directly |
RH | Board Member | 10 % indirectly |
BT | Chairman | 6 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 280 | 28 % | |
LJ 1970 | Ordinary shares | 280 | 28 % |
VJ 1977 | Ordinary shares | 280 | 28 % |
| Ordinary shares | 100 | 10 % | |
BT | Ordinary shares | 60 | 6 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | -70,196 | -13,992 | -9,176 | -14,417 |
Total assets | 309,963 | 406,107 | 437,306 | 463,819 |
Total liabilities | 28,214 | 54,162 | 71,369 | 88,706 |
Total equity | 281,749 | 351,945 | 365,937 | 375,113 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 90,108 | 17,931 | 11,730 | 18,418 |
Operating result | -90,108 | -17,931 | -11,730 | -18,418 |
Financial income/costs | 88 | -14 | -33 | -67 |
Profit before tax | -90,020 | -17,946 | -11,763 | -18,485 |
Total tax & extraordinary income/cost | -19,824 | -3,954 | -2,587 | -4,068 |
Annual Total Result | -70,196 | -13,992 | -9,176 | -14,417 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 0 | 359 | 0 | 0 |
Total current assets | 309,963 | 405,748 | 437,306 | 463,819 |
Total assets | 309,963 | 406,107 | 437,306 | 463,819 |
Short term debt | 1,546 | 7,670 | 13,254 | 16,063 |
Long term debt | 26,668 | 46,492 | 58,115 | 72,643 |
Total liabilities | 28,214 | 54,162 | 71,369 | 88,706 |
Contributed capital | 578,000 | 578,000 | 578,000 | 578,000 |
Retained earnings | -296,251 | -226,055 | -212,063 | -202,887 |
Total equity | 281,749 | 351,945 | 365,937 | 375,113 |
Total equity and liabilities | 309,963 | 406,107 | 437,306 | 463,819 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises